CDXS241220P2500
- 0.03
- 0.000.00%
Codexis Newsroom
Cantor Fitzgerald Maintains Codexis(CDXS.US) With Buy Rating, Maintains Target Price $11
Biofuel Enzyme Global Market Overview 2021-2024 & 2030 With Competitive Analysis of AB Enzymes, BASF, Codexis, DuPont De Nemours, Iogen, Koinklijke, Novonesis, and Transbiodiesel - ResearchAndMarkets.com
Codexis to Participate in Piper Sandler 36th Annual Healthcare Conference
Codexis Price Target Maintained With a $11.00/Share by Cantor Fitzgerald
Codexis Unveils Pioneering Enzymatic Synthesis Data to Enable the Future Manufacturing of RNAi Therapeutics
Codexis Strengthens Board and Updates Bylaws
Codexis Announces Appointment of Raymond De Vré, PhD, to Board of Directors
Craig-Hallum Maintains Codexis(CDXS.US) With Buy Rating
Codexis Announces New Employment Inducement Grants
Codexis to Participate in Upcoming Healthcare Conferences
Benchmark Co. Maintains Codexis(CDXS.US) With Hold Rating
Codexis Analyst Ratings
Benchmark Co. Remains a Hold on Codexis (CDXS)
Codexis, Inc. (NASDAQ:CDXS) Released Earnings Last Week And Analysts Lifted Their Price Target To US$7.17
Craig-Hallum Maintains Codexis(CDXS.US) With Buy Rating, Announces Target Price $9
Stifel Maintains Codexis(CDXS.US) With Buy Rating, Maintains Target Price $5
Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript Summary
Codexis (CDXS) Reports Q3 Loss, Tops Revenue Estimates
Codexis | 10-Q: Q3 2024 Earnings Report
Codexis | 8-K: Codexis Reports Third Quarter 2024 Financial Results